Evidence map›Paper›PMID 32471984›Full record

ArticleScientific reports2020

Signal profiling of the β

Viktoriya Lukasheva, Dominic Devost, Christian Le Gouill, Yoon Namkung, Ryan D Martin, Jean-Michel Longpré, Mohammad Amraei, Yuji Shinjo, Mireille Hogue, Monique Lagacé and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. KCTD Proteins Have Redundant Functions in Controlling Cellular Growth.International journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Signalling of Adrenoceptors: Canonical Pathways and New Paradigms.Handbook of experimental pharmacology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Viktoriya Lukasheva *Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.
Dominic Devost *Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Christian Le Gouill *Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.
Yoon NamkungDepartment of Medicine, Research Institute of the McGill University Health Centre, McGill University, Montréal, Québec, Canada.
Ryan D MartinDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Jean-Michel LongpréInstitut de Pharmacologie and Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Mohammad AmraeiDepartment of Pharmacology and Physiology, Université de Montréal, Centre de Recherche de l'Hôpital Ste-Justine, Montréal, Canada.
Yuji ShinjoGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Mireille HogueDepartment of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.
Monique LagacéDepartment of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.
Billy BretonDepartment of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.
Junken AokiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Jason C TannyDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Stéphane A LaporteDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Graciela PineyroDepartment of Pharmacology and Physiology, Université de Montréal, Centre de Recherche de l'Hôpital Ste-Justine, Montréal, Canada.
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Michel BouvierDepartment of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada. michel.bouvier@umontreal.ca.
Terence E HébertDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada. terence.hebert@mcgill.ca.
Université de Montréal · CAMcGill University · CATohoku University · JPInstitute for Research in Immunology and Cancer · CAMcGill University Health Centre · CAUniversité de Sherbrooke · CA

Funding

CIHR FDN148431CIHR MOP11215CIHR PJT159687
6 · The paper itself

Abstract

A comprehensive understanding of signalling downstream of GPCRs requires a broad approach to capture novel signalling modalities in addition to established pathways. Here, using an array of sixteen validated BRET-based biosensors, we analyzed the ability of seven different β-adrenergic ligands to engage five distinct signalling pathways downstream of the β

Indexed as

Biosensing TechniquesCalciumCRISPR-Cas SystemsGene EditingGTP-Binding Protein alpha Subunits, G12-G13GTP-Binding Protein alpha Subunits, GsHEK293 CellsHumansLigandsPhenotypeReceptors, Adrenergic, beta-1Receptors, Adrenergic, beta-2Signal TransductionCalciumGTP-Binding Protein alpha Subunits, G12-G13GTP-Binding Protein alpha Subunits, GsLigandsReceptors, Adrenergic, beta-1Receptors, Adrenergic, beta-2

Identifiers

PMID32471984
PMCPMC7260363
OpenAlexW3031364957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.